Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 129

    1.

    Linezolid: the first oxazolidinone antimicrobial.

    Lindley DA.

    Ann Intern Med. 2003 Nov 18;139(10):863; author reply 864. No abstract available. PMID: 14623625 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Linezolid for the treatment of serious gram-positive infections.

    McAuley L.

    Issues Emerg Health Technol. 2001 Mar;(15):1-6. No abstract available. PMID: 11902223 [PubMed - indexed for MEDLINE]Related articles

    3.

    Linezolid: implications for neurosurgical infections.

    Nguyen CM, Larive LL, Rhoney DH.

    Neurol Res. 2003 Jan;25(1):22-6. Review.PMID: 12564121 [PubMed - indexed for MEDLINE]Related articles

    4.

    Linezolid: a new class of antibiotic.

    Kupecz D.

    Nurse Pract. 2000 Nov;25(11):62-4. No abstract available. PMID: 11107609 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hospital resource use and cost of treatment with linezolid versus teicoplanin for treatment of serious gram-positive bacterial infections among hospitalized patients from South America and Mexico: results from a multicenter trial.

    López H, Li JZ, Balan DA, Willke RJ, Rittenhouse BE, Mozaffari E, Vidal G, Zitto T, Tang T.

    Clin Ther. 2003 Jun;25(6):1846-71.PMID: 12860502 [PubMed - indexed for MEDLINE]Related articles

    6.

    Linezolid: the first oxazolidinone antimicrobial.

    Johnson JR.

    Ann Intern Med. 2003 Nov 18;139(10):863; author reply 864. No abstract available. PMID: 14623627 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    [Linezolid, an agent from a new class of antibiotics]

    Kuijper EJ, Schippers EF, Bernards AT.

    Ned Tijdschr Geneeskd. 2004 Aug 7;148(32):1577-81. Review. Dutch. PMID: 15382556 [PubMed - indexed for MEDLINE]Related articles

    8.

    Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.

    Plosker GL, Figgitt DP.

    Pharmacoeconomics. 2005;23(9):945-64. Review.PMID: 16153136 [PubMed - indexed for MEDLINE]Related articles

    9.

    An economic evaluation of a European cohort from a multinational trial of linezolid versus teicoplanin in serious Gram-positive bacterial infections: the importance of treatment setting in evaluating treatment effects.

    Nathwani D, Li JZ, Balan DA, Willke RJ, Rittenhouse BE, Mozaffari E, Tavakoli M, Tang T.

    Int J Antimicrob Agents. 2004 Apr;23(4):315-24.PMID: 15081078 [PubMed - indexed for MEDLINE]Related articles

    10.

    [Linezolid, the first oxazolidinone antibiotic]

    Dutronc H, Bocquentin F, Galpérine T, Lafarie-Castet S, Dupon M.

    Med Mal Infect. 2005 Sep;35(9):427-34. Epub 2005 Nov 16. Review. French. PMID: 16297585 [PubMed - indexed for MEDLINE]Related articles

    11.

    Emerging therapies for serious gram-positive bacterial infections: a focus on linezolid.

    Plouffe JF.

    Clin Infect Dis. 2000 Sep;31 Suppl 4:S144-9. Review.PMID: 11017864 [PubMed - indexed for MEDLINE]Related articles

    12.

    Economic evaluation of linezolid versus teicoplanin for the treatment of infections caused by gram-positive microorganisms in Spain.

    Grau S, Aguado JM, Mateu-de Antonio J, Gonzalez P, Del Castillo A.

    J Chemother. 2007 Aug;19(4):398-409.PMID: 17855184 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pharmacoeconomic evaluation of linezolid versus teicoplanin in bacteremia by Gram-positive microorganisms.

    Grau S, Mateu-de Antonio J, Soto J, Marín-Casino M, Salas E.

    Pharm World Sci. 2005 Dec;27(6):459-64.PMID: 16341954 [PubMed - indexed for MEDLINE]Related articles

    14.

    Linezolid: a new antibiotic for gram-positive infections.

    Wilson P.

    Hosp Med. 2001 Nov;62(11):682-6. Review.PMID: 11762099 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Utility of linezolid in cystic fibrosis]

    Girón-Moreno RM, Ruiz-Velasco LM, Buendía V.

    Enferm Infecc Microbiol Clin. 2004 Jun-Jul;22(6):369-70. Spanish. No abstract available. PMID: 15228910 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Summaries for patients. Linezolid.

    [No authors listed]

    Ann Intern Med. 2003 Jan 21;138(2):I44. No abstract available. PMID: 12529109 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Quinupristin/dalfopristin and linezolid: where, when, which and whether to use?

    Livermore DM.

    J Antimicrob Chemother. 2000 Sep;46(3):347-50. Review. No abstract available. PMID: 10980159 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Therapeutic options for Gram-positive infections.

    Rybak MJ.

    J Hosp Infect. 2001 Dec;49 Suppl A:S25-32. Review.PMID: 11926437 [PubMed - indexed for MEDLINE]Related articles

    19.

    [Prolonged treatment with linezolid with good hematologic tolerability]

    Ramos A, García MJ, Blasco F, Valverde ML.

    Rev Esp Quimioter. 2004 Sep;17(3):266-7. Spanish. No abstract available. PMID: 15619657 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [Vancomycin or linezolid as the treatment of choice for grampositive nosocomial pneumonia]

    Márquez-Peiró JF, Climente-Martí M, Jiménez-Torres NV.

    Farm Hosp. 2009 Jan-Feb;33(1):55-6. Spanish. No abstract available. PMID: 19401100 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data